Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Video
  • Podcasts
  • Write for us
  • News for You
  • Covid-19
  • Video
  • Podcasts

Search Results for mrna-1273

Moderna files for Emergency Use Authorization with FDA for mRNA-1273

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative […]

Moderna files for Emergency Use Authorization with FDA for mRNA-1273
2 months ago
Share
0

Phase 1 & 2 Study Reveals CoronaVac COVID-19 Vaccine Candidate Inferior to BNT162B2 & mRNA-1273

A Chinese firm, known as Sinovac, one of the leading COVID-19 vaccine developer contenders, recently revealed results from a peer-reviewed […]

Phase 1 & 2 Study Reveals CoronaVac COVID-19 Vaccine Candidate Inferior to BNT162B2 & mRNA-1273
2 months ago
Share
2

COVID-19 Vaccine Candidate mRNA-1273 (94.5%) beats BNT162b2 (90%) in Interim Analysis: Moderna Prepares to Submit Application for EUA with FDA

Moderna Inc. (Nasdaq: MRNA), the developer of the messenger RNA-based vaccine candidate known as mRNA-1273, reports that the independent NIH […]

COVID-19 Vaccine Candidate mRNA-1273 (94.5%) beats BNT162b2 (90%) in Interim Analysis Moderna Prepares to Submit Application for EUA with FDA
2 months ago
Share
0

University of Illinois Chicago Gears up to Recruit up to 1,000 Diverse Participants for the COVID-19 Vaccine Trial Involving mRNA-1273

The University of Illinois’ Health System launches the COVID-19 vaccine trial testing Moderna’s mRNA-1273 starting this Monday. Led by University […]

University of Illinois Chicago Gears up to Recruit up to 1,000 Diverse Participants for the COVID-19 Vaccine Trial Involving mRNA-1273
5 months ago
Share
0

U.S. Gov Commits $1.5b to Moderna for mRNA-1273 as BARDA & DOD Negotiators get Shrewder

Last week Moderna announced that the U.S. government secured 100 million doses of its COVID-19 vaccine candidate known as mRNA-1273 […]

U.S. Gov Commits $1.5b to Moderna for mRNA-1273 as BARDA & DOD Negotiators get Shrewder
5 months ago
Share
0

Atlanta’s Emory University a Hub in the War Against COVID-19 as Phase 3 mRNA-1273 Vaccine Trial First Patient Dosed

At the onset of the COVID-19 pandemic, the national research apparatus rapidly responded, mobilizing a powerful clinical trial site network […]

Atlanta’s Emory University a Hub in the War Against COVID-19 as Phase 3 mRNA-1273 Vaccine Trial First Patient Dosed
6 months ago
Share
0

Wake Forest Baptist Health & Javara Research as a Care Option Partnership Put to the Test on the mRNA-1273 COVID-19 Vaccine Trial

By September 2018, Javara and Wake Forest Baptist Health announced their intention to deliver the clinical research as a care option […]

Wake Forest Baptist Health & Javara Research as a Care Option Partnership Put to the Test on the mRNA-1273 COVID-19 Vaccine Trial
6 months ago
Share
0

mRNA-1273 COVID-19 Vaccine Trial Goes to the Piney Woods of Mississippi Led by Hattiesburg Clinic

Hattiesburg Clinic in Hattiesburg, Mississippi, was selected by Moderna as one of the 89 clinical investigational site for the pivotal […]

mRNA-1273 COVID-19 Vaccine Trial Goes to the Piney Woods of Mississippi Led by Hattiesburg Clinic
6 months ago
Share
0

Moderna mRNA-1273 Clinical Trials Kicks off in Sacramento at Benchmark Research

Kelli Benedetti, one of the first of eight participants to join the Moderna phase 3 COVID-19 vaccine trial at Benchmark […]

Moderna mRNA-1273 Clinical Trials Kicks off in Sacramento at Benchmark Research
6 months ago
Share
1

Valley of the Sun’s Hope Research Institute Selected by Moderna to Conduct Phase 3 Clinical Trial Testing mRNA-1273

Hope Research Institute in Phoenix, Arizona, part of the “Valley of the Sun” region was selected by Moderna for its Phase […]

Valley of the Sun’s Hope Research Institute Selected by Moderna to Conduct Phase 3 Clinical Trial Testing mRNA-1273
6 months ago
Share
0

Posts navigation

Older posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.